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Abstract
Mycobacterium tuberculosis complex (MTBC) genomes contain 2 large gene families termed pe and ppe. The function of pe/
ppe proteins remains enigmatic but studies suggest that they are secreted or cell surface associated and are involved in
bacterial virulence. Previous studies have also shown that some pe/ppe genes are polymorphic, a finding that suggests
involvement in antigenic variation. Using comparative sequence analysis of 18 publicly available MTBC whole genome
sequences, we have performed alignments of 33 pe (excluding pe_pgrs) and 66 ppe genes in order to detect the frequency
and nature of genetic variation. This work has been supplemented by whole gene sequencing of 14 pe/ppe (including 5
pe_pgrs) genes in a cohort of 40 diverse and well defined clinical isolates covering all the main lineages of the M. tuberculosis
phylogenetic tree. We show that nsSNP’s in pe (excluding pgrs) and ppe genes are 3.0 and 3.3 times higher than in non-pe/
ppe genes respectively and that numerous other mutation types are also present at a high frequency. It has previously been
shown that non-pe/ppe M. tuberculosis genes display a remarkably low level of purifying selection. Here, we also show that
compared to these genes those of the pe/ppe families show a further reduction of selection pressure that suggests neutral
evolution. This is inconsistent with the positive selection pressure of ‘‘classical’’ antigenic variation. Finally, by analyzing such
a large number of genes we were able to detect large differences in mutation type and frequency between both individual
genes and gene sub-families. The high variation rates and absence of selective constraints provides valuable insights into
potential pe/ppe function. Since pe/ppe proteins are highly antigenic and have been studied as potential vaccine
components these results should also prove informative for aspects of M. tuberculosis vaccine design.
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Introduction
Mycobacterium tuberculosis, the main causative agent of tubercu-
losis in humans, is a member of the M. tuberculosis complex
(MTBC), a closely related group of slow-growing pathogenic
mycobacteria. Recent studies of MTBC evolution have revealed
that the M. tuberculosis genome appears to be a composite genome
created by frequent horizontal gene transfer events in a broad,
genetically diverse, progenitor species prior to an evolutionary
bottleneck or selective sweep around 35,000 years ago [1].
Divergence of the rare, smooth colony forming tubercle bacilli
M. canetti seems to immediately predate this bottleneck/selective
sweep while all other members of the MTBC are the result of the
clonal expansion of a small number of surviving bacteria. This
recent clonal expansion with the concurrent absence of horizontal
gene transfer explains the relatively high degree of genetic
homogeneity (99.9%) observed between MTBC members despite
differences in their phenotypic characteristics and host ranges
[2,3,4]. Whole genome sequencing of several M. tuberculosis strains,
along with M. bovis and M. africanum, has confirmed this genetic
homogeneity and revealed many other interesting biological
aspects [5,6,7].
One of the surprises emerging from the analysis of the first
sequenced M. tuberculosis genome (the laboratory strain H37Rv)
was the discovery of two large gene families, designated pe and ppe,
that in H37Rv comprise 99 and 69 members respectively and
together account for around 10% of the organism’s genomic
coding potential [5]. Pe genes are characterised by the presence of
a proline-glutamic acid (PE) motif at positions 8 and 9 within a
highly conserved N-terminal domain consisting of around 110
amino acids. Similarly, ppe genes contain a proline-proline-
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glutamic acid (ppe) at positions 7–9 in a highly conserved N-
terminal domain of approximately 180 amino acids. The C-
terminal domains of both pe and ppe protein families are highly
variable in both size and sequence and often contain repetitive
DNA sequences that differ in copy number between genes [5].
The pe and ppe gene families can be divided into sub-families
based on similarities in their N-terminal regions and the phy-
logenetic relationships between each gene sub-family have been
previously described, demonstrating that their evolutionary ex-
pansions are linked to the duplications of the ESAT-6 (esx) gene
clusters [8]. Ppe genes can be subdivided into 5 subfamilies, the
most numerous of which are the ppe_svp (24 members) and the
ppe_mptr (major polymorphic tandem repeat) subfamilies (23
members) (Fig. 1a). Pe genes can also be divided into 5 sub-
families, the largest of which, the polymorphic GC-rich-repetitive
sequence (pe_pgrs), comprises 65 members in H37Rv (Fig. 1b). This
sub-family is characterised by a C-terminal domain that contains
multiple tandem repeats of a glycine-glycine-alanine (Gly-Gly-Ala)
or a glycine-glycine-asparagine (Gly-Gly-Asn) motif. Phylogenetic
analysis indicates that the emergence of the large pe_pgrs and
ppe_mptr subfamilies is a recent evolutionary event, with their
presence being restricted to members of the MTBC and close
relatives such as M. marinum and M. ulcerans [8].
The high pe/ppe gene content of the MTBC suggests an
important biological role for their respective proteins. However,
their precise function is unknown although recent studies have
provided some intriguing clues. In pathogenic organisms it is
generally found that proteins that are directly exposed to host
immune surveillance show higher levels of polymorphism than
that found in general housekeeping proteins [9]. This is thought to
reflect their in volvement in antigenic variation and immune
evasion. Many pe/ppe proteins have been found to be highly
Figure 1. Phylogenetic reconstruction of the evolutionary relationships between the members of the pe and ppe protein families.
A. Phylogeny of the ppe protein family. The phylogenetic tree was constructed from the phylogenetic analysis done on the 180 aa N-terminal
domains of the ppe proteins. The tree was rooted to the outgroup Rv3873 (ppe68), shown to be the first ppe insertion into the ESAT-6 (esx) gene
clusters [8]. Figure reproduced from reference 8 with permission of the authors. B. Phylogeny of the pe protein family. The phylogenetic tree was
constructed from the phylogenetic analysis done on the 110 aa N-terminal domains of the pe proteins. The tree was rooted to the outgroup Rv3872
(pe35), shown to be the first pe insertion into the ESAT-6 (esx) gene clusters [8]. Figure reproduced from reference 8 with permission of the authors.
doi:10.1371/journal.pone.0030593.g001
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immunogenic and several groups have investigated this aspect of
their biology with regard to vaccine production (for example,
[10,11]). Persuasive evidence now exists that many M. tuberculosis
pe/ppe proteins are cell surface located [12,13,14,15] and that
others are probably secreted [16,17] and this, in conjunction with
their immunogenicity and the well established polymorphic nature
of their C-terminal repeats, has led to the suggestion that they may
well be involved in antigenic variation and immune evasion [5].
Indeed, several studies have revealed varying degrees of pe/ppe
sequence polymorphism between M. tuberculosis clinical isolates.
Talarico and colleagues have reported a high degree of poly-
morphism within the pe_pgrs33, pe_pgrs16 and pe_pgrs26 genes
[18,19,20]. Similar results have also been found for ppe18 [21].
Less sensitive analysis based on the size of DNA repeats in the C-
terminal region of ppe34 and ppe8 have also revealed a high
frequency of polymorphism [12,22]. In addition, some pe/ppe
genes have been reported to display elevated levels of IS6110
integration [23,24,25,26,27,28] and homologous recombination
[26,29,30,31]. However, sequence analysis of 4 pe (pe5, pe11, pe18
and pe31) and 4 ppe (ppe9, ppe27, ppe41 and ppe50) genes found
polymorphism to be limited or absent [32]. Along with sequence
variation, gene expression alterations may contribute to antigenic
variation and these have also been noted in pe/ppe genes from
different M. tuberculosis strains [33,34,35]. For example, ppe44
shows limited sequence diversity between strains (only isolates of
the Beijing genotype were found to be polymorphic) whereas
transcript levels of the gene are highly variable [35]. Numerous
other reports have documented variation in pe/ppe transcription
levels under different environmental and experimental conditions
[36,37,38,39]. Furthermore, there does not appear to be a global
regulator of pe/ppe expression [36,40], suggesting a complex
regulatory network and a high degree of plasticity in their
expression repertoire.
It has been proposed that pe/ppe proteins can aid M. tuberculosis
pathogenesis by negatively influencing host immunity [5] and
recently Toll-like receptor 2 (TLR2) has assumed a prominent role
in this theory. For example, Basu et al showed that pe_pgrs33 is
able to enhance the expression of tumour necrosis factor alpha
(TNFa) in a TLR2-dependent manner leading to macrophage
apoptosis [41]. Interestingly, deletions within the PGRS domain
(as is often seen in clinical isolates) inhibited this ability. Ppe
proteins have also been shown to function in a TLR2-dependent
manner. Nair et al demonstrated that ppe18 binds to TLR2 which
stimulates IL-10 production in macrophages [42]. This leads to
an anti-inflammatory Th2 type immune response. Evidence also
exists to suggest that pe_pgrs proteins may be able to inhibit
antigen processing and/or presentation [43] and it has been
proposed that the Gly-Ala repeats in the C-terminal PGRS
domains are able to inhibit proteasomal degradation of the N-
terminal PE domain [44] thus inhibiting antigen processing by
CD8+ T cells in a manner similar to that seen in Epstein – Barr
virus nuclear antigen 1 [45]. Several other lines of evidence also
suggest a major role for pe/ppe proteins in mycobacterial path-
ogenesis. For example, recent work has shown that pe_pgrs33
localises to host cell mitochondria where it is able to induce
apoptosis and primary necrosis [46]. Studies demonstrating in-
creased mycobacterial growth in macrophages and subsequent
macrophage necrosis of pe_pgrs33 expressing strains (as oppose to
pe_pgrs33 negative strains) have also been reported [47,48] and
other studies have documented an attenuated phenotype with the
knockout of specific pe/ppe genes [49,50] or the upregulation of
specific pe/ppe genes upon infection [38,51].
Evidence for other diverse alternative or additional pe/ppe
functions also exists. In silico analysis of PGRS protein sequences
reveal that at least 56 pe_pgrs members contain multiple nona-
peptide repeats (GGXGXD/NXUX, where X= any amino acid
and U=a large non-polar hydrophobic residue) that are predicted
to be calcium binding motifs [52]. The authors suggest that these
motifs might be involved in the initial attachment of M. tuberculosis
to host alveolar macrophages. PGRS domains have also been
implicated in cellular structure and colony morphology [14] and in
the binding of fibronectin [53]. A possible role in iron uptake has
also been proposed for ppe37 following the finding that it is
upregulated under low iron conditions [54]. It is also notable that
pe/ppe genes are often found paired within operons with the pe
gene located upstream of the ppe gene. Pe/ppe genes within these
operons are cotranscribed and physically interact with each
other and transcription of both is required for correct cellular
localization [55,56]. This is emphasised by the findings of Strong
and colleagues who failed in numerous attempts to determine
the crystal structures of individual pe and ppe proteins. Co-
expression and copurification of the proteins coded by the linked
genes Rv2431c (pe25) and Rv2430c (ppe41) was successful,
however, and the crystal structure revealed a 1:1 pe25/ppe41
protein dimer where helices from each protein are predicted to
interact and form a stable complex. The structure implies a
docking site for an additional protein and suggests a role in
signal transduction [56].
Here, we have used recently acquired whole genome sequence
data from 18 isolates representing a broad spectrum of the
MTBC phylogeny to investigate variation in 33 pe (excluding
pe_pgrs) and 66 ppe genes. We have supplemented this data by
selecting 14 pe and ppe genes (including 5 pe_pgrs) and performing
whole gene sequencing on a cohort of 40 clinical isolates
representing a broad and well characterised spectrum of the M.
tuberculosis phylogeny. We hypothesise that if pe/ppe proteins are
involved in immune evasion and antigenic variation their genes
will have undergone rapid evolutionary change, as demonstrated
by high levels of DNA sequence polymorphism and evidence for
diversifying selection compared to other M. tuberculosis genes.
Previous work on this theme [12,18,19,20,21,22,32] has pro-
duced conflicting results that may be due to the lack of sensitivity
of the analysis technique, the decision to examine genes that
belong to a particular pe or ppe sub-family that might show
abnormal variation levels, or the decision to examine clinical
isolates that are too closely related to reveal polymorphic
differences. The resultant comparative gene analysis presented
here provides new insights into the variation and evolution of
these genes along with their potential role in providing the
pathogen with a source of antigenic variation.
Results
Comparative gene analysis using whole genome
sequences
A total of 66 ppe and 33 pe genes were analysed. Unfortunately,
due to the extensive repetitiveness of their C-terminal regions and
the inherent difficulties encountered in sequencing through re-
petitive regions using the third generation short read sequencing
techniques, the pe_pgrs genes of most publicly available whole
genome sequences were incomplete or of low sequence quality and
could not be included in this analysis. Variability estimates for
ppe38/71 and ppe50 could not be determined due to the difficulty
in obtaining a reference sequence. Ppe38/71 are completely ho-
mologous in most cases and are located in a hypervariable region
that is prone to homologous recombination, gene conversion,
IS6110 integration and large deletion events [26]. Ppe50 is also
highly variable and displays numerous different sequence types
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due to large deletions and other sequence variations [32]. Due to
the exclusion of genes with notations suggesting potential sequence
errors, an average of 15.2 and 16.5 genomes (from a possible
maximum of 18) were analysed for each ppe and pe gene
respectively. Full details of all variations detected can be seen in
tables S1, S2, S3.
Confirmation of whole genome sequence accuracy
In order to ascertain the accuracy of the whole genome se-
quences used in our analysis we obtained the original DNA used in
the sequencing process to determine the F11, CPHL_A, K85, T17
and T92 sequences. A total of 40 variations observed in the pe/ppe
genes of these 5 isolates were reanalysed by amplifying the sur-
rounding region by PCR and using standard Sanger sequencing
methodology to sequence the amplicons. A variety of variations
were chosen for analysis and these comprised sSNP’s, nsSNP’s,
frameshifts, and an in-frame deletion. We also ensured that some
of the variations detected in the large ppe_mptr genes, ppe5/6 and
ppe7/8, were analysed since it could be suggested that mistakes are
more likely to be made here due to the highly repetitive nature of
their C-terminal domains. Table S4 lists the variations, primer
details and results of our analysis. Four of the 40 variations (10%)
were found to be erroneous in the publicly available whole genome
sequences. One of these (T17, ppe28) appears to be due to an
assembly error while another (CPHL_A, ppe13) involves a long
poly C region at the 39 end of the gene. The other 2 errors involve
a SNP or single bp deletion. The 10 variations that were checked
in the ppe5/6 and 7/8 genes were all confirmed indicating that the
large ppe_mptr genes were not more likely to produce sequencing
errors than the smaller less complex genes.
Number of structural protein variants
Various aspects of genetic variation between the homologous
genes may be analysed. First we wished to determine the number
of predicted different structural variants of each pe/ppe protein,
based on the observed genetic variations, as a proportion of the
total number of isolates analysed. Thus, sSNP’s were ignored,
variations that were specific to multiple isolates from a single
lineage were counted as a single variant and single isolates that
contained more than 1 variation were still counted as a single
variant. Results for the ppe gene analysis are shown in Fig. 2a.
They reveal a high level of variation across all subfamilies, with
only one gene (ppe51) showing no variation in all genomes
analysed. Subfamily V (the MPTR subfamily) shows many genes
with extreme levels of variation. By distinguishing between
different types of mutation it is notable that certain genes display
alternate mechanisms of variation. For example, homologous re-
combination events, particularly between closely related ppe genes
in close physical proximity, are shown to be responsible for a high
degree of variation within certain genes (ppe57/58/59 and ppe18/
19/60). Other macromutational events (whole or partial gene
deletions and IS6110 integrations) were found to be responsible
for a significant proportion of the variation in several genes. Also
notable is the finding that macromutational events do not con-
tribute to variation in the most hypervariable genes of the MPTR
subfamily. Six genes in particular (ppe5/6, 7/8, 24, 34, 54 and 55)
show extreme variation and 5 of these have a variation index of 1
(indicating that each isolate had a unique sequence). These 6 genes
are all large (between approximately 3.1 and 10.0 kb) and reveal
mutations including nsSNP’s, frameshifts and in-frame indels. The
sequences of these 6 hypervariable genes were further compared
between 3 closely related genomes, KZN 1435, KZN 605 and
KZN 4207 [57] in order to ascertain whether they were evolving
at a rate that would enable us to distinguish even between
extremely closely related isolates. For each gene the sequence in
all 3 genomes was identical. The sequences of four of the hyper-
variable ppe genes (ppe24, 34, 54 and 55) were also compared
between the index case and 2 transmission chain endpoint isolates
of the Harlingen cluster [58,59]. An average of 84% of the coding
region for each of these genes was available for analysis. No
variations were observed. These results indicate that while these
ppe genes are hypervariable across the full phylogeny of M.
tuberculosis, they do not evolve at a rate fast enough to distinguish
between extremely closely related isolates.
A similar analysis of the ppe (excluding pe_pgrs) genes revealed
agenerally lower level of variation with many of the genes showing
no variation across the analysed genomes (Fig. 2b). Macro-
mutational events, including homologous recombination, were rare.
Pe/ppe variation levels in comparison with other M.
tuberculosis genes
In order to ascertain whether the variation levels of the pe and
ppe genes differed from other M. tuberculosis genes we compared our
results to those obtained by Hershberg and colleagues who
identified the SNP’s present in 89 non-pe/ppe genes comprising
65,829 bp, from 107 MTBC isolates [60]. This study identified a
total of 231 nsSNP’s, which when divided by the total number of
nucleotides multiplied by the number of isolates gives a nsSNP
frequency of 231/(65,8296107) = 0.32761024 nsSNP’s per nu-
cleotide. Similar calculations using our ppe data required the
exclusion of several genes. Ppe38/71 and ppe50, which exhibit
extreme levels of macro-mutational variation, were excluded.
Ppe18, 19, 24, 34, 54, 55, 57, 58, 59 and 60 were also excluded
because of extreme variability or frequent homologous recombi-
nation events which resulted in difficulty in determining the
consensus sequence of the gene. The remaining 54 ppe genes
comprise 100,657 bp and contain 163 nsSNP’s and the average
number of isolates analysed per gene was 15.17. This results in a
nsSNP frequency of 163/(100,657615.17) = 1.06761024 nsSNP’s
per nucleotide. This value is approximately 3.3-fold greater than
that found in the non-pe/ppe MTBC genes [60] despite the
exclusion of the most variable ppe genes. Similarly, the 33 pe
(excluding pgrs) genes comprised 21,726 bp and contained
35 nsSNP’s with an average isolate number per gene of 16.5,
resulting in a nsSNP frequency of 35/(21,726616.5) = 0.9766
1024 nsSNP’s per nucleotide. This value is approximately 3.0-fold
higher than that found in non-pe/ppe MTBC genes [60]. These
results confirm that nsSNP’s occur at a far higher frequency in pe/
ppe genes than in non-pe/ppe genes.
Whole gene sequencing results of 14 pe and ppe genes
Complete results for all variations found from whole gene
sequencing of 14 pe and ppe genes from 40 phylogenetically diverse
clinical isolates covering the whole M. tuberculosis phylogenetic tree
(PGG1, 2 and 3 strains including members of all the main lineages
EAI, CAS, Beijing, LAM, Haarlem, LCC and T) are shown in
Table S5. Our sequencing of 3 pe genes (pe35, 11 and 3) and 6 ppe
genes (ppe68, 2, 44, 10, 42 and 62) confirmed the results found for
these genes in our in silico gene analysis. In each case lineage
specific variations were consistent between the 2 different analyses.
Interestingly, our 3 EAI samples failed to show the ppe62 G1690A
SNP which was present in 2 (T17 and T46) of the 4 EAI samples
analysed in silico. This suggests that our EAI isolates are relatively
closely related and do not reflect the large genetic diversity
observed within this group [60].
Particular interest lies in our analysis of the 5 pe_pgrs genes since
the pgrs subfamily could not be analysed using in silico methods.
Three of these genes (pe_pgrs16, 26 and 33) have previously been
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analysed for their variation [18,19,20]. Our replication of this
work (using better defined M. tuberculosis lineages) confirms that all
3 of these genes display extremely high variation with in-frame
indels within the pgrs repetitive region comprising a large pro-
portion of the mutations in each case. These indels were often
large. For example, in the pe_pgrs16 gene the 2 EAI isolates
SAWC1659 and SAWC2493 both possess 2 deletions of 66 bp
and 600 bp and all CAS family isolates possess 2 deletions of
45 bp and 42 bp in pe_pgrs33 (Table S5). Pe_pgrs18 has previously
been reported as being part of a duplicated gene pair (with
pe_pgrs17) that shows evidence of homologous recombination and
gene conversion events [30]. Our results for pe_pgrs18 confirmed a
high level of homologous recombination with pe_pgrs17. We were
also able to confirm the presence of the 12/40 polymorphism in
the Haarlem and LCC groups that appears to result from gene
conversion with pe_pgrs17 [30]. Details of the variability character-
Figure 2. Sequence variation levels in ppe and pe genes. A. Calculations of sequence variation in 64 ppe genes. Synonymous variations have
been ignored. The Y axis shows the proportion of sequences that show variation predicted to result in amino acid changes. A value of 1 indicates that
all analysed sequences were unique. Average number of genomes analysed per gene= 15.2. Genes have been grouped together according to their
subfamily [8] by colour and subfamilies are also separated by dotted lines. Each vertical bar is subdivided into micromutations (nsSNP’s, frameshifts,
small in-frame indels) in dark shading and macromutations (homologous recombination, IS6110 integration, partial and whole gene deletions) in
light shading. Ppe38 and ppe50 were not included due to hypervariability at the macromutational level [26,30] and the difficulty in establishing a
consensus sequence. For details of all variations detected see Tables S1 and S2. B. Calculations of sequence variation in 33 pe (excluding pgrs) genes.
Synonymous variations have been ignored. Average number of isolates analysed per gene= 16.5. The genes from subfamily V (pgrs subfamily, yellow)
are those which are classified as members of this subfamily by their N-terminal amino acid sequences [8] but that do not include the long PGRS C-
terminal region. For details of all variations detected see Tables S1 and S3.
doi:10.1371/journal.pone.0030593.g002
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istics of pe_pgrs62 have not previously been reported. Results for this
gene were surprising because despite being the same size as most of
the other analysed pe_pgrs genes it showed very little variation and
no in-frame indels were observed (Table S5). Additional in silico
analysis of this gene in M. bovis confirmed its invariant nature. A
closer inspection of the gene’s predicted amino acid sequence
revealed that it does not possess the C-terminal multiple tandem
repeats of Gly-Gly-Ala and Gly-Gly-Asn typical of pgrs proteins.
Taken together, our results suggest that pe_pgrs genes generally
display high variation levels with in-frame indels making a large
proportion of mutations. However, mutational mechanisms and
levels of variation can differ greatly between individual genes
implying functional variation within this subfamily.
The 252 bp deletion identified in the pe_pgrs16 gene of isolate
SAWC 2185 (Haarlem, F2) (Table S5) was further analysed in
order to determine how variable this mutation was within both the
F2 family and other members of the same cluster as SAWC 2185.
Isolates from 36 different F2 clusters as well as 4 isolates from the
same cluster were examined. All other members of the cluster to
which isolate SAWC 2185 belongs, along with 27 of the additional
F2 clusters, were found to contain this mutation. However, isolates
representing the remaining F2 clusters lacked the mutation con-
firming the presence of within-family variation for this mutation.
Analysis of selective constraints in pe/ppe genes
One of the major findings of the MTBC genetic diversity study
of Hershberg and colleagues [60] was the low level of purifying
selection compared to other bacteria, as assessed by the ratio of
nonsynonymous to synonymous SNP’s (dN/dS) in 89 non-pe/ppe
genes. A dN/dS ratio of ,1 is considered to indicate purifying
selection, dN/dS=1 suggests an absence of selection (i.e. neutral
evolution) and dN/dS.1 indicates positive or diversifying
selection. In our analysis of 54 ppe genes (excluding the genes
described above) we discovered a total of 220 SNP’s, of which 163
(74%) were nonsynonymous (Table S2). The average pairwise dN/
dS ratio for the concatenated ppe genes was 1.045. This is
substantially higher than the already extremely high value of 0.57
reported for the non-pe/ppe M. tuberculosis genes [60] and suggests
an absence of selection pressure. Similarly, in our analysis of 33 pe
genes we detected a total of 47 SNPs, of which 35 (74%) were
nonsynonymous (Table S3). The average pairwise dN/dS ratio for
the concatenated pe genes was 1.000, again far higher than the
value previously obtained for non-pe/ppe genes [60] and again
suggesting an absence of selection pressure. We also calculated the
dN/dS value for the 3 pe_pgrs genes that show a ‘‘typical’’ pgrs
variation profile (pe_pgrs16, 26 and 33 – see above) using the SNPs
identified in our current study in addition to those detected
previously [18,19,20]. A total of 63 SNPs were found in these 3
genes of which 43 (68%) were nonsynonymous. The average
pairwise dN/dS ratio for the 3 concatenated pe_pgrs genes was
0.869, a value once again close to that indicating neutral evolution.
Discussion
Although polymorphisms in certain M. tuberculosis pe and ppe
genes have been previously documented, this study is the first to
make use of publicly available MTBC whole genome sequences, as
well as a comprehensive set of 40 clinical isolates covering the
known M. tuberculosis phylogenetic tree and all major M. tuberculosis
strain lineages including EAI, CAS, Beijing, Haarlem, LAM, LCC
and T, to produce an extensive analysis of pe/ppe gene variation.
Unfortunately, the large pe_pgrs subfamily was not able to be
analysed using these methods due to a lack of sequencing accuracy
but our own sequencing analysis of selected pe_pgrs genes, in
conjunction with those of previous investigators, also provides
important insights into genetic variation within this subfamily.
The first important observation made was the confirmation that
pe and ppe genes display a high frequency of variation (Fig. 2) and
that this variation exceeds that seen in other MTBC genes.
Hershberg and colleagues previously analysed MTBC genetic
diversity by sequencing 89 non-pe/ppe genes (classified as either
‘‘housekeeping’’, ‘‘virulence’’ or ‘‘surface’’) in 107 MTBC isolates
[60]. Compared to these genes, the nsSNP frequency in the ppe
and pe (excluding pe_pgrs) genes in our analysis was approximately
3.3 and 3.0 times greater, respectively. Several qualifying points
should be emphasised when considering these values. Our quality
assurance analysis of 40 selected SNP’s from the whole genome
sequences revealed that 4 were incorrect (Table S4), indicating
an overestimation of variation frequency of approximately 10%.
However, it should also be noted that our ppe variation values were
obtained without the inclusion of the 12 most variable ppe genes
which were excluded from the analysis due to the difficulty in
determining a consensus sequence. The inclusion of these genes
would undoubtedly result in a significant increase in observed ppe
variation. In addition, many of the ppe genes that were included in
our analysis displayed high levels of variation that were not due to
nsSNP’s. Indeed, the mutational spectrum seen in ppe genes was
extensive. The most common mutations observed were nsSNP’s
and frameshifts caused by small indels. However, many large ppe
genes of the mptr subfamily often display in-frame indels, certain
groups of genes undergo frequent homologous recombination
events and, as previously reported, ppe39 and ppe40 are particularly
susceptible to IS6110 insertions [27]. Figure 2a reveals that
members of the ppe_mptr subfamily have a generally higher
frequency of mutation but this does not apply consistently to all
members of this group.
Interestingly, although the pe (excluding pgrs) genes revealed far
lower variation than the ppe’s (Fig. 2), the frequency of nsSNP’s was
similar to that of the ppe’s and was found to be approximately triple
that of the non-pe/ppe genes analysed previously [60]. Protein
changes in these genes were generally due to nsSNP’s and small
indels leading to frame shifts. In-frame indels and macromutations
(whole or partial gene deletions and IS6110 integrations) were
rare. The lower variation in these genes probably reflects a strong
functional constraint of the pe protein. It has previously been
shown that pe proteins and the pe domain of pe_pgrs proteins are
responsible for cell wall localisation [15]. This is presumably
essential for optimal protein function and mutations that hinder
this process would therefore be subject to strong negative selection
pressures.
Our own sequencing analysis of 5 pe_pgrs genes showed that, in
general, variation within the pe_pgrs subfamily exists at far higher
levels than in non-pgrs pe members and that this increase in
variation is largely caused by a higher frequency of in-frame indels
within the C-terminal pgrs region. These results support the
findings of Talarico and colleagues who have previously reported
analysis of genetic polymorphism in pe_pgrs33, 16 and 26
[18,19,20]. We show that the deletions in these 3 genes are often
large (for example, in EAI isolates 666 bp has been deleted from
pe_pgrs16, Table S5). The fact that large deletions were often found
in multiple isolates from the same lineage suggests that these
mutations are not subjected to strong purifying selection forces.
The phenotypic consequences of these deletions may include a
reduction in macrophage apoptosis caused by a decrease in TNFa
production [41] and, at an epidemiological and clinical level, be
associated with clustering and a lack of lung cavitations [19]. Our
analysis of pe_pgrs18 and 62 has provided additional interesting
information relating to pe_pgrs variation since neither of these
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genes displayed the ‘‘typical’’ variation pattern seen in pe_pgrs33,
16 and 26 (Table S5). Variation in pe_pgrs18 was found to be
largely caused by gene conversion with pe_pgrs17. These genes are
in close physical proximity, have high sequence homology, and are
presumably the result of a recent duplication event. A previous
study has documented homologous recombination between these
genes and has identified a polymorphism present in one or both of
these genes and used it to infer details of the evolution and clonal
expansion of the MTBC [30]. Genetic variation in pe_pgrs62 has
not been reported previously and we chose this gene for analysis
because studies have shown that it is a T cell antigen with vaccine
potential [61,62,63] and that its PGRS domain is able to elicit a
strong antibody response [64]. The PGRS domain of pe_pgrs62 is
atypical as it lacks the Gly-Gly-Ala or Gly-Gly-Asn repeats found
in most members of this subfamily. Interestingly, the amount of
variation seen in this gene was far less than in the more typical
pe_pgrs genes with only 4 SNPs (of which only 2 were non-
synonymous) seen in our 40 clinical isolates. This lack of genetic
variation is especially interesting since pe_pgrs62 can stimulate both
cell-mediated and humoral based host immunity and might
therefore be expected to undergo significant levels of antigenic
variation. Taken together, these results reveal that while variation
in pe_pgrs genes is generally very high, this variation, along with
the dominant type of mutational mechanism, can differ greatly
between genes. The finding of low variation in a highly immu-
nogenic pe_pgrs member lacking the typical PGRS domain also
implies functional variation in certain members of this sub-family.
Another major finding of this study was that selection appears to
be absent in pe/ppe genes. Most genomic regions in all organisms
are subjected to strong purifying selection pressures. Within the
Actinobacteria, for example, pairwise genome-wide comparisons
result in a general dN/dS value of 0.15–0.20 [60]. This value
appears to be fairly typical of both prokaryotic and eukaryotic
organisms [65]. The recent comparative sequence analysis of 89
genes in 107 MTBC isolates [60] found an average pairwise dN/
dS ratio of 0.57, a value far higher than that found in other
bacteria and an indication that purifying selection is severely
reduced in the MTBC on a general genomic level. In pe/ppe genes
specifically, a high ratio of nonsynonymous to synonymous SNP’s
has previously been noted [6,20] and it has also been shown that
these genes are under greater selection for amino acid substitutions
than other M. tuberculosis genes [66]. Our pairwise dN/dS ratio
calculations for 54 ppe and 33 pe genes were 1.045 and 1.000
respectively, suggesting that selection pressure on these genes is
extremely limited or altogether absent. Although our analysis of
pe_pgrs genes was numerically limited, the pairwise dN/dS ratio
was also close to 1 (0.869), again indicating a selection pressure
close to neutral. This result is surprising because pe/ppe proteins
are thought to provide antigenic variation and therefore be
subjected to positive, rather than neutral, selection pressure. Thus,
our results indicate that variation in these proteins is inconsistent
with ‘‘classical’’ antigenic variation. It should be noted, however,
that these results are an average of the gene families as a whole
and that individual genes might be subjected to greater or lesser
selective pressures. Evidence that pe/ppe genes are the major
targets of positive selection in M. tuberculosis comes from a recent
paper that examined the genomes of H37Rv and H37Ra [67]. Of
the 12 genes that were found to be positively selected in these
strains 6 were from the pe or pe_pgrs families. Our results also need
to be interpreted in light of the report of Comas and colleagues
[68] who found that the antigenic epitopes (excluding pe and ppe
proteins) of M. tuberculosis are highly conserved and that there
appears to be a strong selection pressure against sequence diversity
in these regions. This finding was unexpected and is also
inconsistent with the classical model of an evolutionary immuno-
logical arms race between pathogen and host and the authors
favour the explanation that the host immune response is, par-
adoxically, beneficial to the pathogen. Despite the fact that our pe
and ppe dN/dS values were far higher than those found for M.
tuberculosis antigens in the Comas study, this explanation may also
apply (to a lesser extent) to pe and ppe proteins and explain why
their dN/dS values were less than those of typical antigens in other
organisms.
Although our results suggest that pe/ppe proteins do not act
as typical antigenic variants it is also important to consider the
impact of population genetics on dN/dS values. The dN/dS ratio
is a popular measure of selection pressure not only because it is
simple and robust but also because of the simple interpretation of
dN/dS,1 as negative selection, dN/dS= 1 as neutral selection
and dN/dS.1 as positive selection. This analysis was originally
designed for comparisons between sequences from divergent
lineages or species and it has recently been shown that the
standard signature of positive selection (dN/dS.1) does not hold
for comparisons within a population [69]. It can sometimes
be difficult to determine the appropriate evolutionary time-scale
(distinct lineages/species versus numerous isolates from a single
population) associated with a dataset of microbial sequences and it
is possible that some of the more closely related sequences in our
dataset have not diverged sufficiently for this analysis to be
appropriate. If this is the case it is unlikely that our dN/dS values
would alter drastically. We would, however, predict that our values
are underestimates and therefore conclude that a mild positive
selection pressure is acting upon these genes. Many of the pe/ppe
genes present within the MTBC have homologues in the closely
related, but phylogenetically distinct, species M. marinum [70] and
we suggest that a comparison between these genes could provide a
more accurate estimate of the evolutionary pressures they have
been subjected to.
We hope that our results will allow for a more directed ap-
proach towards the use of pe/ppe proteins as vaccine components
since it is possible that the high levels of polymorphism observed in
certain members of these protein families could limit their
effectiveness in some cases. This has been highlighted in a recent
mathematical modelling analysis that has predicted the negative
impact on vaccine efficacy that may occur when mycobacterial
strain diversity is not considered [71]. For example, the Mtb72F
vaccine comprises the 2 recombinant proteins pepA (Rv0125) and
ppe18 (Rv1196). Mtb72F has been shown to have a protective
effect against challenges with two M. tuberculosis laboratory ref-
erence strains (H37Rv and Erdmann) in numerous animal models,
including a primate model [72,73,74,75]. However, a recent study
has shown that over 20% of M. tuberculosis strains taken from 2
geographical regions contain mutations that alter at least 1 amino
acid in the ppe18 protein, many of which are in regions predicted
to be T cell epitopes [21]. Our study confirms a high rate of ppe18
variation and shows that it is predominantly due to homologous
recombination between ppe18, ppe19 and ppe60, which have
extremely high sequence similarity. These results suggest that the
Mtb72F vaccine could have limitations in a clinical setting and
that, in hindsight, a pe/ppe protein that displays higher sequence
conservation across many strains may have been a more effective
vaccine candidate. An example of this is pe_pgrs62 which has also
been investigated for its vaccine potential with promising results
[61,62]. This highly immunogenic, atypical pgrs protein showed
extremely limited sequence variation across our cohort of isolates
(Table S5) and might be expected to provide more consistent
protection against a variety of M. tuberculosis strains. The data
available for immunogenicity at the pe/ppe epitope level is limited
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however and it should be noted that variable regions of pe/ppe
genes may be less immunogenic and less important for an immune
response. It should also be noted that pe/ppe proteins probably
have functional variation and that some may have a limited role in
immune function.
The exact nature of pe/ppe function in the host cell is yet to
be determined. However, our results also provide some additional
insights and allow us to speculate on potential mechanisms of
action for these proteins. When the high levels of pe/ppe sequence
variation are considered in conjunction with the high inter-strain
expressional variation [33,34,35] it is apparent that there is likely
to be a huge diversity of pe/ppe expressional and functional
variation across the MTBC. This would lead to a situation where
only extremely closely related isolates have identical functional and
expressional profiles across the entire pe/ppe spectrum. We note
that this situation has parallels to the classical MHC class I and II
systems where highly polymorphic MHC loci produce multiple
alleles which, despite their structural and functional similarities,
are distinct with regards to the antigenic peptides they present to
CD4+ and 8+ T cells. It may be speculated that the large number
of polymorphic pe/ppe proteins have evolved in response to the
multiple MHC alleles expressed by host populations and that
specific pe/ppe proteins are adapted to preferentially coexist
alongside specific MHC alleles. The absence of selection exerted
on pe/ppe genes may be interpreted as both a result of immune
pressure selecting for antigenic variants and an adaptation for
these proteins to function alongside new or rare MHC alleles that
have not previously been encountered in the bacteria’s evolution-
ary history. Although purely speculative, this theory is consistent
with the large pe/ppe expansion within the MTBC (and in the
closely related species M. marinum which is a natural pathogen of
fish), it’s functional and expressional variability, and the finding
that some pe/ppe proteins appear to interfere with antigen pro-
cessing [43,44]. The true nature of pe/ppe function remains one
of the great mysteries of M. tuberculosis pathogenesis however and
many additional functional studies will probably be required
Table 1. Details of 18 whole genome sequence isolates used
for in silico comparative gene analysis.
Isolate Lineage Reference
T92 Lineage 1. PGG1, EAI family [57]
T17 Lineage 1. PGG1, EAI family [57]
T46 Lineage 1. PGG1, EAI family [57]
EAS054 Lineage 1. PGG1, EAI family [57]
94_M4241A Lineage 2. PGG1, Beijing family [57]
02_1987 Lineage 2. PGG1, Beijing family [57]
T85 Lineage 2. PGG1, Beijing family [57]
C strain Lineage 4. PGG2, low copy clade [57]
CDC1551 Lineage 4. PGG2, low copy clade [6]
Haarlem Lineage 4. PGG2, Haarlem family [57]
F11 Lineage 4. PGG2, LAM family [57]
GM1503 Lineage 4. PGG2, LAM family [57]
KZN1435 Lineage 4. PGG2, LAM family [57]
98-R604_INH-RIF-EM Lineage 4. PGG2, LAM family [57]
H37Rv Lineage 4. PGG3 [5,77]
CPHL_A Lineage 5. PGG1, West Africa-1
(M. africanum)
[57]
K85 Lineage 6. PGG1, West Africa-2
(M. africanum)
[57]
M. bovis AF2122/97 Animal lineage [76]
Each analysed genome sequence is listed along with its lineage number [78],
Principal Genetic Group (PGG) [2] and family group.
doi:10.1371/journal.pone.0030593.t001
Table 2. Details of clinical isolates used in this study.
Isolate Lineage
South African IS6110
Lineage [84]
SAWC 1659 1, PGG1, EAI -
SAWC 2493 1, PGG1, EAI -
SAWC 4981 1, PGG1, EAI -
SAWC 2803 3, PGG1, CAS F34
SAWC 2240 3, PGG1, CAS F20
SAWC 2666 3, PGG1, CAS F33
SAWC 974 3, PGG1, CAS F25
SAWC 2088 2, PGG1, Atypical Beijing F31
SAWC 2701 2, PGG1, Atypical Beijing F27
SAWC 2076 2, PGG1, Typical Beijing F29
SAWC 1430 4, PGG2 F3
SAWC 3656 4, PGG2, LAM F26
SAWC 2576 4, PGG2, LAM F15
SAWC 2525 4, PGG2, LAM F9
SAWC 1815 4, PGG2, LAM F11
SAWC 1733 4, PGG2, LAM F13
SAWC 3100 4, PGG2, LAM F14
SAWC 1595 4, PGG2, Quebec/S F28
SAWC 198 4, PGG2, ‘‘1 bander’’ F110
SAWC 2073 4, PGG2, LCC – ‘‘2 bander’’ F120
SAWC 233 4, PGG2, LCC – ‘‘3 bander’’ F130
SAWC 861 4, PGG2, LCC – ‘‘4 bander’’ F140
SAWC 1162 4, PGG2, LCC – ‘‘5 bander’’ F150
SAWC 716 4, PGG2, Pre-Haarlem F19
SAWC 1748 4, PGG2, Pre-Haarlem F24
SAWC 1127 4, PGG2, Haarlem-like F6
SAWC 103 4, PGG2, Haarlem-like F7
SAWC 386 4, PGG2, Haarlem F1
SAWC 1645 4, PGG2, Haarlem F10
SAWC 1841 4, PGG2, Haarlem F4
SAWC 2185 4, PGG2, Haarlem F2
SAWC 239 4, PGG3, T F22
SAWC 2901 4, PGG3, T F16
SAWC 1608 4, PGG3, T F5
SAWC 1109 4, PGG3, T F23
SAWC 4302 4, PGG3, T F18
SAWC 1956 4, PGG3, T F17
SAWC 1290 4, PGG3, T F21
SAWC 300 4, PGG3, T F12
SAWC 1870 4, PGG3, T F8
Each clinical isolate along with its lineage number [78], PGG group [2],
spoligotype family group status [88] and South African IS6110 lineage [84] is
listed.
doi:10.1371/journal.pone.0030593.t002
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before we are able to gain a more complete understanding of
their role.
Materials and Methods
Ethics statement
We recovered sputum specimens from the National Health
Laboratory Service (NHLS) after routine processing. None of the
authors were directly involved in sputum collection. This study
was approved by the Stellenbosch University Health Research
Ethics Committee (approval reference number N10/04/126).
Informed consent was not required as we received samples from
the NHLS after routine processing. This was approved by the
Stellenbosch University IRB.
In silico whole genome sequence analysis
Sequence selection details. Analysis of pe and ppe genes
from the following 18 fully sequenced MTBC genomes was
conducted: M. bovis strain AF2122/97 [76], H37RV [77],
CDC1551 [6], CPHL_A (M. africanum), K85 (M. africanum), T92,
T46, T48, EAS054, 94_M4241A, 02_1987, T85, C strain,
Haarlem, F11, GM1503, KZN 1435 and 98-R604_INH-RIF-
EM [57]. Details of the phylogenetic placements of each isolate
are shown in Table 1. At least 1 representative from all 7 major
MTBC lineages (including the animal lineage) [78] are included in
this study apart from lineage 3 (CAS lineage). Ppe genes from the
fully sequenced isolates KZN 605 and KZN 4207 [57] as well as
the Harlingen transmission chain [58] were also analysed in
specific instances. Orthologues of each gene were located by
BLAST searches using the H37Rv gene sequence as the type
standard. Gene sequences obtained from the Broad institute [57]
were not used if they contained the following messages suggesting
possible low sequence quality: ‘‘At least one base has a quality
score ,10’’, ‘‘EST-based feature contains predicted/unverified
ORF’’ or ‘‘Frame Shift: Sequence Error’’. Sequence alignments
were done using CLUSTALW [79].
Confirmation of whole genome sequence accuracy. Ge-
nomic DNA from 5 of the whole genome sequenced isolates (F11,
CPHL_A, K85, T17 and T92) was used to check the accuracy of 40
variations that were found in various pe and ppe genes (Table S4).
Primers were designed to amplify a region surrounding the variation
point and PCRs and sequencing of the amplicons were performed as
described below. Recently, a number of nucleotides in the H37Rv
sequence, including some within pe and ppe genes, were found to be
incorrect [78]. These SNPs were corrected before analysis.
dN/dS values. Due to the general low level of SNPs present
when analysing individual genes, a concatenated alignment for
each gene category (ppe, pe and pe_pgrs) was generated combin-
ing all individual genes. Prior to concatenation the consensus
sequence of each gene was aligned with the equivalent sequence
containing all SNP’s identified using CLUSTALW [79]. Other
variations (eg frameshifts or in-frame indels) that had been
Table 3. Details of the pe and ppe genes examined by whole gene sequencing.
Gene Rv number
Size in H37Rv
(bp) Sublineage* Variability in literature Comments
pe35 Rv3872 300 I No data. Ancestral pe protein. Present in RD1 region. Highly
immunogenic, eg [89].
pe11, lipX Rv1169c 303 IV Invariable [32]. B cell responses in subgroups of patients [90]. Putative
lipase [77].
pe3 Rv0159c 1407 V (PGRS subfamily) No data. Atypical sublineage V protein. Not pgrs.
pe_pgrs16 Rv0977 2772 V (PGRS subfamily) Highly variable [20]. Upregulated in mouse model [39,91].
pe_pgrs18 Rv0980c 1374 V (PGRS subfamily) Known to undergo homologous
recombination with pe_pgrs17 [30].
Highly upregulated during the early stages of M.
tuberculosis invasion of the blood-brain barrier [91].
High sequence identity to pe_pgrs17 implying recent
duplication event [30].
pe_pgrs26 Rv1441c 1476 V (PGRS subfamily) Highly variable [20]. Downregulated in mouse model [39].
pe_pgrs33 Rv1818c 1497 V (PGRS subfamily) Highly variable [18,19]. Localised in cell wall [14] and surface exposed [15].
SigA-mediated transcription downregulated during
stationary phase and under stress conditions [92].
Implicated in pathogenicity and host immune
responses [43,47,48,61,62,90,93,94]. Possible inhibitor
of antigen processing [44].
pe_pgrs62 Rv3812 1515 V (PGRS subfamily) No data. Elicits strong antibody response [64]. T cell antigen
[61,62].
ppe68 Rv3873 1107 I No data. Ancestral ppe protein.
ppe2 Rv0256c 1671 II (PPW subfamily) No data. PPW subfamily.
ppe44 Rv2770c 1149 IV (SVP subfamily) Limited diversity. Alteration in
Beijing isolates [35].
Variable expression in clinical isolates [35]. Expressed
during subcutaneous and intravenous infection by M.
bovis BCG in BALB/c mice [95].
ppe10 Rv0442c 1464 V (MPTR subfamily) No data. Ancestral ppe MPTR protein.
ppe42 Rv2608 1743 V (MPTR subfamily) Variable in clinical isolates [96]. Elicits a high humoral and low T cell response [96].
ppe62 Rv3533c 1749 V (MPTR subfamily) No data. MPTR protein.
*As defined in reference [8].
Each gene sequenced in this study is listed along with its phylogenetic position within its family and any additional information regarding its protein’s function available
in the literature.
doi:10.1371/journal.pone.0030593.t003
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identified were ignored. The resultant alignment files for each
gene were concatenated using DnaSP [80] and pairwise dN/dS
values were determined by subjecting the alignment to the DnaSP
program package.
DNA sequencing of clinical isolates
Bacterial culture conditions, molecular typing and strain
selection. Sputum samples were obtained from primary health
care clinics in metropolitan Cape Town, South Africa. This
region has a very high tuberculosis incidence and has been used
extensively in an ongoing, prospective epidemiological study [81].
According to the National Tuberculosis Control Program in line
with the Directly Observed Therapy Short-course strategy,
diagnosis of tuberculosis is made by sputum smear microscopy
in new cases, and by smear microscopy and culture in retreatment
cases. We recovered these sputum specimens for our study area
of interest from the National Health Laboratory Service (NHLS)
after routine processing. M. tuberculosis strains present in spu-
tum culture were genotyped using IS6110 RFLP [82] and
spoligotyping [83,84]. DNA fingerprints were analysed with
GelCompar software using the unweighted-pair group method,
average linkages and Dice coefficients [85]. Isolates with an
IS6110 similarity index of$65% were grouped into strain lineages
[86]. Fourty isolates of divergent lineages were selected for
analysis. Table 2 shows phylogenetic details of these clinical
isolates.
Selection of pe/ppe genes for whole gene sequence
analysis. A phylogenetic analysis of both the pe and ppe gene
families has previously been reported [8]. This has demonstrated
that each gene family can be divided into several subfamilies
(Fig. 1). In order to maximise the scope of our analysis we selected
genes representative of several different sub-families in each case.
Where possible, genes for which some aspect of their biology (such
as antigenicity) had been previously reported were chosen. A total
of 14 pe/ppe genes were selected. These included the ancestral
member of each family as well as 5 pe_pgrs genes. Details of the
selected genes are listed in Table 3.
PCR and sequencing. Primer sequences for the 14 selected
genes are listed in Table S6. PCRs were done in a reaction
mixture containing 0.1 mg template DNA, 3 ml GC-rich solution,
1.5 ml 106 buffer containing MgCl2, 2.4 ml 10 mM dNTP’s,
0.6 ml each primer (5 pmol/ml) and 0.12 ml FastStart Taq (Roche,
Germany) made up to 15 ml with H2O. Amplification comprised
an initial 6 min template denaturation followed by 35 cycles using
the appropriate annealing temperature (listed in Table S6) and
an extension time of 30 s to 1 min 30 s depending on the length of
the amplicon. PCR product was checked by electrophoresis
through an agarose gel and an aliquot was treated with ExoSAP-
IT (USB). Sequencing was performed using an ABI 3100
automated DNA sequencer. Sequence editing and manipulation
was done using the BioEdit Sequence Alignment Editor [87].
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